This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Does Stimulant Treatment Lead to Substance Use Disorders?

Stephen V. Faraone, PhD, and Timothy Wilens, MD

Published: September 1, 2003

Article Abstract

The authors examine the relationship between the treatment of attention-deficit/hyperactivitydisorder (ADHD) with stimulants and substance use disorders by reviewing their published meta-analysisof 6 studies and adding preliminary data from a seventh study. Despite some discrepanciesamong the findings of the 7 studies, the meta-analysis demonstrated that exposure to stimulanttherapy for ADHD does not increase the risk for developing substance use disorders but is, in fact,protective against it. Stimulant treatment of ADHD appears to reduce the risk for substance use disordersby 50%, thus reducing the risk for substance use disorders in ADHD youth to levels well withinthe normal population risk. The implication of this finding is unquestionably one with enormous valueboth clinically and as a matter of public health.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 64

Quick Links: Addiction , Substance Use Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...